Abstract
purpose. In a previous study, it was determined that TGFβ induces cataractous
changes in the rat lens in vitro. The purpose of the present study was
to determine whether the introduction of biologically active TGFβ
into the vitreous stimulates cataractous changes in the rat lens in
situ.
methods. TGFβ was injected into the vitreous of the left eye of anesthetized
adult male Wistar rats. The right eye received sterile vehicle as a
control. Three to four months after injection, animals were killed, and
lenses were enucleated and examined for cataractous changes.
results. All lenses from control eyes remained transparent and maintained normal
cellular architecture throughout. In contrast, lenses from
TGFβ-injected eyes displayed cloudiness in the cortex. In some
lenses, distinct opacities were also apparent at the equator and
extending some distance toward the anterior and posterior poles.
Histologically, the opacities corresponded to subcapsular plaques
containing aberrant cells and accumulations of extracellular matrix. In
addition, cortical fibers in the anterior and posterior of all lenses
displayed variable degrees of swelling, and many retained their nuclei.
In some regions, the fiber cells appeared to have degenerated to form
large homogeneous areas. The cellular architecture of the equator of
these lenses was also disrupted and, in the most severe case, no bow
zone was apparent with nucleated cells extending to the posterior pole.
conclusion. The introduction of active TGFβ into the vitreous induced lenses to
undergo cataractous changes. In addition to the TGFβ-induced changes
in the epithelium that were reported previously, cataractous changes
observed in this study also involved the lens fiber cells and resembled
changes observed in human posterior subcapsular and cortical
cataracts.
Previously, we reported that TGFβ stimulates lens epithelial
cells to undergo aberrant morphologic and molecular changes that mimic
those documented in some forms of human cataract. In lens epithelial
explants TGFβ induces capsule wrinkling, the formation of
spindle-shaped cells that contain α-smooth muscle actin and cell
death.
1 2 Furthermore, distinct anterior opacities develop
in whole lenses cultured with TGFβ.
3 4 Histologically,
the opacities correspond with subcapsular plaques, which contain
spindle-shaped cells and accumulations of extracellular matrix,
including type I collagen.
3 Morphologic and molecular
features similar to those induced by TGFβ in vitro have been
described in human anterior and posterior subcapsular cataract and in
aftercataract (posterior capsular opacification).
5 6 7 8 9 10 11 12 13 These findings have led to the hypothesis that TGFβ may be involved
in the etiology of these forms of cataract.
Analysis of ocular media of patients who are to undergo cataract
surgery suggests that TGFβ levels are elevated compared with ocular
media collected from eye bank eyes.
14 15 However, it is
not clear whether the elevated level of TGFβ in these patients was
the inducing factor for the cataract or a consequence of the cataract.
The purpose of this study was to investigate whether elevating active
TGFβ levels in the ocular media in vivo induces cataractous changes
in the lens similar to those previously reported in studies in vitro. A
whole animal model was used, in which TGFβ was injected into the
vitreous of adult male rats. Lenses from these animals have been shown
to be both highly responsive and sensitive to the cataractogenic
influence of TGFβ.
4 Here, we describe the cellular and
molecular changes that are induced in the lens by intravitreal
injection of TGFβ.
All experimental procedures used in this study conformed to the
ARVO Statement for the Use of Animals in Ophthalmic and Vision
Research. Thirteen adult Wistar rats (9-months old) were used in this
study. Because adult male rats had been shown to be highly susceptible
to the cataractogenic influence of TGFβ, these animals were
exclusively used in this study.
4 Each rat was anesthetized
using 5% halothane in 70% NO
2-30%
O
2 then maintained in 1.5% halothane in the same
gas mixture for the duration of all surgical procedures. The rat was
positioned on its right side on an operating table under a dissecting
microscope with its left eye uppermost. Using a fine needle (Insulin
Syringe, Becton Dickinson, Franklin Lakes, NJ; external diameter, 360μ
m), a small puncture was made in the region of the limbus. A very
fine needle (Hamilton, Reno, NV; external diameter, 200 μm) attached
to a 10-μl syringe was immediately lowered through the puncture hole
into the vitreous using a micromanipulator, and 3 μl (approximately
60 ng) TGFβ, was slowly injected into the vitreous. The needle was
left in position for 30 to 60 seconds and then slowly withdrawn to
minimize fluid loss from the eye. Injections were performed under a
dissecting microscope to ensure correct positioning of the needle and
to monitor loss of fluid from the eye. It should be noted that the
maximum effective dose of TGFβ to which lens cells were exposed as a
result of this procedure is unknown. Injection would generate a
positive pressure, which would probably lead to displacement of some
TGFβ out of the vitreous compartment. In addition, the outcome would
be influenced by inhibitors of TGFβ known to be present in the
vitreous.
16
After injection, each animal was placed in a warmed (26°C),
humidified recovery box and allowed to regain consciousness. Each rat
was then anesthetized for a second time, and the same protocol was used
to inject the right eye with 3 μl control vehicle, either
acetonitrile-trifluoroacetic acid or HCl-phosphate-buffered saline
(PBS)-BSA (depending on the source of TGFβ). Rats were monitored
regularly (at least twice weekly) for infection associated with the
injection site. Most rats were killed at 15 weeks, one was killed at 6
weeks, and another was killed at 12 weeks. No time-dependent
differences were noted.
All lenses from eyes injected with TGFβ displayed some loss of
lens clarity and changes in cellular architecture, although the
response varied from lens to lens. Note that none of the lenses in this
study, control or TGFβ-treated, displayed evidence of rupture of
fibers through the lens capsule, as would happen if the needle tip had
penetrated the capsule during the injection procedure. Furthermore,
when sections of control and TGFβ-treated eyes were examined
histologically, no differences in extralenticular tissues were
detected.
Previous investigations, both in vitro and using transgenic mice,
have suggested a role for TGFβ in the formation of subcapsular
cataracts.
1 3 4 18 19 In the present study, a whole-animal
model was used to investigate the effect of introducing active TGFβ
into the vitreous. A variety of morphologic and molecular changes
resulted that were similar to changes associated with several common
forms of cataract in humans.
Intravitreal injection of TGFβ induced disruption of the normally
highly aligned arrangement of the fiber cells. Fibers appeared swollen
and retained their nuclei, and in some regions there was evidence of
degeneration of fibers into rounded fragments and large homogeneous
areas. Swollen, degenerating fibers were apparent from the anterior
through the equator and into the posterior of the lens. TGFβ also
induced severe disruption of the ordered arrangement of nuclei at the
lens equator and in the bow region of these lenses. Furthermore, many
fiber cells atypically retained their nuclei beyond the bow region. In
all these respects, changes in lenses from eyes injected with TGFβ
resemble those associated with human cortical
cataract.
20 21
Lenses from eyes injected with TGFβ also displayed changes
characteristic of posterior subcapsular cataract. In lenses exposed to
TGFβ, nucleated cells were observed extending from the disrupted
equator to the posterior pole of the lens as described in posterior
subcapsular cataract.
17 22 Furthermore, swelling and
deterioration of the fiber cells extending from beneath the posterior
capsule to deep within the cortex of the lens, another feature of
posterior subcapsular cataract, was common.
Epidemiologic studies indicate that posterior subcapsular cataract and
cortical cataract commonly occur together in mixed
cataracts.
23 24 25 This has resulted in some confusion in
establishing exactly which morphologic features arise in each form of
cataract. Subsequently, there appears to be considerable overlap in the
features of cortical cataract and posterior subcapsular cataract. For
example, both these forms of cataract contain swollen and degenerated
fibers that have lost their regular alignment.
20 22 17 Results presented in the present study suggest that both forms may
share a common etiology in which TGFβ is implicated.
The introduction of active TGFβ into the vitreous compartment also
resulted in the formation of anterior opacities, indicating that
diffusion of TGFβ from the vitreous to aqueous compartments had
occurred. The opacities corresponded with subcapsular plaques and were
surrounded by regions of severe fiber disruption. Accumulations of
extracellular matrix were common within the plaques. These opacities
are similar to the anterior subcapsular cataracts described previously
in lenses cultured with TGFβ.
3 4 The present study,
therefore, provides additional strong support for the role of TGFβ in
the etiology of anterior subcapsular cataract.
Exposure to TGFβ in vivo appears to induce more pronounced
cataractous changes in the posterior and cortical regions of the lens
than those observed when lenses are cultured with TGFβ in vitro.
Generally, changes induced by TGFβ in vitro are restricted to the
epithelium. Lenses cultured with TGFβ develop numerous distinct
opacities across the anterior surface that correspond with subcapsular
plaques.
3 4 Some subtle changes in the posterior and
cortical fibers have been observed previously in lenses cultured with
TGFβ but only in lenses from ovariectomized rats, which are
particularly susceptible to the cataractogenic effects of
TGFβ.
4
Several factors may contribute to the observed differences in the
effects of TGFβ on the lens in vivo and in vitro. In studies in
vitro, the entire lens is immersed in medium containing TGFβ. In
contrast, in the present study in vivo, TGFβ was introduced directly
into the vitreous chamber; therefore, the initial and presumably
greatest TGFβ insult was inflicted on the posterior region of the
lens. Another factor may be the duration of the experiment. In studies
in vitro, the time that lenses may be cultured without deterioration is
limited (up to 7 days for lenses from adult rats), whereas lenses were
generally not examined until 15 weeks after exposure to TGFβ in vivo.
TGFβ-induced changes, either direct or secondary, may take
longer to manifest in cortical fibers than in epithelial cells. Cells
would also have more time to migrate posteriorly along the capsule in
the study in vivo.
Differentiating fiber cells in the cortical region have the potential
to respond directly to TGFβ. TGFβ receptors have been detected by
immunolocalization and in situ hybridization in these cells as well as
in the equatorial region and the lens epithelium.
26 However, the observed swelling of cortical fibers may be a secondary
response, the result of osmotic imbalance due to TGFβ-induced
disruption of the epithelium. This phenomenon does not appear to be the
result of nonspecific damage associated with the injection procedure,
because no such changes were observed in control lenses. Further
investigation is required to determine the precise mechanisms involved
in the cortical fiber response.
TGFβ is known to be present in the ocular environment. The ocular
media contain TGFβ and both mRNA and protein have been detected
within the lens.
16 18 Normally, TGFβ bioavailability to
the lens appears to be tightly regulated. Mechanisms that contribute to
suppression of TGFβ activity include its production in a latent form
and binding to regulatory molecules.
27 28 16 Recent work
in this laboratory has indicated that the ocular media contain
inhibitors of TGFβ. Vitreous in particular has been shown to strongly
inhibit TGFβ activity, demonstrated by its effectiveness in blocking
the morphologic changes induced by TGFβ in lens epithelial explants
in vitro.
16 At least part of the inhibitory activity of
the ocular media may be attributable to the presence ofα
-2-macroglobulin.
16
Although the ocular media contain TGFβ inhibitory molecules, it
is clear that their effects can be overcome. For example, in the
present study rats that received a single intravitreal injection of
TGFβ subsequently developed cataracts. Similarly, in humans it has
been reported that patients who received intraocular TGFβ to promote
healing of macular holes later exhibited an unusually high incidence of
cataract.
29 Furthermore, transgenic mice that overexpress
TGFβ specifically in the lens developed subcapsular
cataracts.
19 Elucidating the mechanisms and molecules that
are involved in regulating TGFβ activity in the ocular media, and in
the eye in general, represents an important area for future study that
may lead to new strategies for preventing or slowing TGFβ-induced
cataract.
The present study adds further support to the hypothesis that TGFβ is
involved in the etiology of subcapsular cataract, in both the anterior
and posterior hemispheres of the lens. In addition, the results
indicate that TGFβ may be involved in the etiology of at least some
cortical cataracts. Having now established this in vivo model for
TGFβ-induced cataract, it will be possible to use it in future
studies to assess the effects of cataract prevention strategies in the
whole animal.
Supported by Grant R01 EY03177 from the National Eye Institute, U.S.
Department of Health, and the National Health and Medical Research
Council of Australia. AH was supported by a University of Sydney
Faculty of Medicine Postgraduate Scholarship and a University of Sydney
U2000 Postdoctoral Research Fellowship.
Submitted for publication March 1, 1999; revised June 10, 1999; accepted July 6, 1999.
Commercial relationships policy: N.
Corresponding author: John W. McAvoy, Department of Anatomy and
Histology (F13), University of Sydney, Sydney, NSW, Australia
2006. E-mail:
[email protected]
The authors thank Roland Smith and Clive Jeffery for their
assistance with the photography.
Liu J, Hales AM, Chamberlain CG, McAvoy JW. Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor-β. Invest Ophthalmol Vis Sci
. 1994;35:388–401.
[PubMed]Hales AM, Schulz MW, Chamberlain CG, McAvoy JW. TGF-β1 induces lens cells to accumulate α-smooth muscle actin, a marker for subcapsular cataracts. Curr Eye Res
. 1994;13:885–890.
[CrossRef] [PubMed]Hales AM, Chamberlain CG, McAvoy JW. Cataract induction in lenses cultured with transforming growth factor-β. Invest Ophthalmol Vis Sci
. 1995;36:1709–1713.
[PubMed]Hales AM, Chamberlain CG, Murphy CR, McAvoy JW. Estrogen protects lenses against cataract induced by TGFβ. J Exp Med
. 1997;185:273–280.
[CrossRef] [PubMed]Font RL, Brownstein S. A light and electron microscopic study of anterior subcapsular cataracts. Am J Ophthalmol
. 1974;78:972–984.
[CrossRef] [PubMed]McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes. Ophthalmology
. 1983;90:1548–1553.
[CrossRef] [PubMed]Novotny GEK, Pau H. Myofibroblast-like cells in human anterior subcapsular cataract. Virchows Arch
. 1984;404:393–401.
[CrossRef] Frezzotti R, Caporossi A, Mastrangelo D, et al. Pathogenesis of posterior capsular opacification. II: histopathological and in vitro culture findings. J Cataract Refract Surg.
. 1990;16:353–360.
[CrossRef] [PubMed]Schmitt–Graff A, Pau H, Spahr R, et al. Appearance of alpha-smooth muscle actin in human eye lens cells of anterior capsular cataract and in cultured bovine lens-forming cells. Differentiation
. 1990;43:115–122.
[CrossRef] [PubMed]Kappelhof J, Vrensen GFJM. The pathology of after-cataract. Acta Ophthalmol Suppl
. 1992;205:13–24.
[PubMed]Hatae T, Ishibashi T, Yoshitomo F, Shibata Y. Immunocytochemistry of type I-IV collagen in human anterior subcapsular cataracts. Graefes Arch Clin Exp Ophthalmol
. 1993;231:586–590.
[CrossRef] [PubMed]Namiki M, Tagami Y, Morino I, Kano M, Sugiura T. Findings from slit lamp and histological examination of the anterior capsule in patients with severe anterior capsular shrinkage and opacities after implantation of intraocular lenses. Nippon Ganka Gakkai Zasshi
. 1993;97:716–720.
[PubMed]Nasisse MP, Dykstra MJ, Cobo LM. Lens capsule opacification in aphakic and pseudophakic eyes. Graefes Arch Clin Exp Ophthalmol
. 1995;233:63–70.
[CrossRef] [PubMed]Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-β and a small (<3500 daltons) inhibitor of thymocyte proliferation. J Immunol
. 1990;144:3021–3027.
[PubMed]Jample HD, Roche N, Stark WJ, Roberts AB. Transforming growth factor-β in human aqueous humor. Curr Eye Res
. 1990;9:963–969.
[CrossRef] [PubMed]Schulz MW, Chamberlain CG, McAvoy JW. Inhibition of transforming growth factor-β-induced cataractous changes in lens explants by ocular media and α-2-macroglobulin. Invest Ophthalmol Vis Sci
. 1996;37:1509–1519.
[PubMed]Eshagian J. Human posterior subcapsular cataracts. Trans Ophthalmol Soc UK
. 1982;102:364–368.
[PubMed]Gordon–Thomson C, de Iongh RU, Hales AM, Chamberlain CG, McAvoy JW. Differential cataractogenic potency of TGFβ1, -β2 and -β3 and their expression in the postnatal rat eye. Invest Ophthalmol Vis Sci
. 1998;39:1399–1409.
[PubMed]Srinivasan Y, Lovicu FJ, Overbeek PA. Lens-specific expression of transforming growth factor beta1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest
. 1998;101:625–634.
[CrossRef] [PubMed]Mikuni I. Histological comparison of senile posterior subcapsular cortical cataract and experimental posterior subcapsular cortical cataract induced by vincristine sulfate. Tokai J Exp Clin Med
. 1980;5:243–250.
[PubMed]Vrensen G. Aging of the human eye lens: a morphological point of view. Comp Biochem Physiol
. 1995;111:519–532.
[CrossRef] Greiner JV, Chylack LT. Posterior subcapsular cataracts: histopathologic study of steroid-associated cataracts. Arch Ophthalmol
. 1979;97:135–144.
[CrossRef] [PubMed]Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with cataract in the 1971–1972 National Health and Nutrition Examination Survey. Am J Epidemiol
. 1983;118:239–249.
[PubMed]Leske MC, Chylack LT, Wu SY. The Lens Opacities Case-Control Study: risk factors for cataract. Arch Ophthalmol
. 1991;109:244–251.
[CrossRef] [PubMed]The Italian-American Cataract Study Group. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol.
. 1991;133:541–553.
[PubMed]de Iongh RU, Gordon–Thomson C, Chamberlain CG, McAvoy JW. Age-related
competence of TGF-β response in rat lens epithelium correlates with
receptor expression. [ARVO Abstract]. Invest Ophthalmol Vis Sci.. 1996;37((3))S983.Abstract nr 4507
Miyazono K, Ichijo H, Heldin CH. Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors
. 1993;8:11–22.
[CrossRef] [PubMed]Rifkin DB, Kojima S, Abe M, Harpel JG. TGF-beta: structure, function, and formation. Thromb Haemost
. 1993;70:177–179.
[PubMed]Thompson J, Glaser B, Sjaarda R, Murphy R. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol
. 1995;119:48–54.
[CrossRef] [PubMed]